Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostatic Neoplasms, Prostatectomy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03177460
What this trial is testing

Daratumumab or FMS Inhibitor JNJ-40346527 Before Surgery in Treating Patients With High-Risk, Resectable Localized or Locally Advanced Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaStage III Prostate Cancer AJCC v8Stage IIIA Prostate Cancer AJCC v8+3 more
M.D. Anderson Cancer Center 33
Not applicableActive Not RecruitingNCT05830838
What this trial is testing

Daily Adaptive Post-Prostatectomy With Stereotactic Ablative Radiotherapy in Patients With Prostate Cancer

Who this might be right for
Malignant Prostate Neoplasm
Mayo Clinic 50
Early research (Phase 1)Study completedNCT05332340
What this trial is testing

Safety, Tolerability and Pharmacokinetics (PK) Evaluation of BZ371A, Topically Administered

Who this might be right for
Erectile Dysfunction Following Radical ProstatectomyErectile DysfunctionProstate Cancer+1 more
Biozeus Biopharmaceutical S.A. 12
Early research (Phase 1)Study completedNCT00450229
What this trial is testing

Diindolylmethane in Treating Patients Undergoing Surgery for Stage I or Stage II Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateProstate CancerStage I Prostate Cancer+1 more
National Cancer Institute (NCI) 45
Not applicableStudy completedNCT06284135
What this trial is testing

MICHL-trial: Impact of Peritoneal Bladder Flap in RARP Patients on Lymphoceles

Who this might be right for
Lymphocele After Surgical Procedure
Martini-Klinik am UKE GmbH 1,080
Testing effectiveness (Phase 2)Active Not RecruitingNCT03047135
What this trial is testing

Olaparib in Men With High-Risk Biochemically-Recurrent Prostate Cancer Following Radical Prostatectomy, With Integrated Biomarker Analysis

Who this might be right for
Prostate
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 51
Large-scale testing (Phase 3)Active Not RecruitingNCT04134260
What this trial is testing

Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE Trial

Who this might be right for
Prostate AdenocarcinomaStage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8+2 more
NRG Oncology 586
Large-scale testing (Phase 3)Study completedNCT00002874
What this trial is testing

Radiation Therapy With or Without Bicalutamide for Recurrent pT3N0 Prostate Cancer After Radical Prostatectomy

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 840
Not applicableActive Not RecruitingNCT06985004
What this trial is testing

Predicting Operational Difficulties and Outcomes of RARP Based on Preoperative Assessment - Introducing the PIODO Questionnaire

Who this might be right for
Prostate CancerRobot-Assisted Laparoscopic Radical Prostatectomy
Pomeranian Medical University Szczecin 288
Not applicableEnded earlyNCT03755492
What this trial is testing

Initiative to Minimize Disparities in Postoperative Prostate Cancer Care

Who this might be right for
Post Prostatectomy
Albert Einstein Healthcare Network 24
Not applicableUnknownNCT06154499
What this trial is testing

Archive Prostate. Observational Study of Patients Who Underwent Radical Prostatectomy Surgery

Who this might be right for
Prostate Cancer
IRCCS San Raffaele 1,784
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07282197
What this trial is testing

Darolutamide+ADT Post-RP w/o ePLND in hrPC: Briganti 2019

Who this might be right for
Prostate Cancer
Peking University First Hospital 40
Not applicableUnknownNCT00850941
What this trial is testing

Radiation Therapy for Rising Prostate Specific Antigen (PSA) Post-prostatectomy

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 146
Testing effectiveness (Phase 2)Study completedNCT00069888
What this trial is testing

A Phase II Trial of Adjuvant Docetaxel in Patients At High Risk of Relapse Following Prostatectomy

Who this might be right for
Prostate Cancer
Sanofi 83
Not applicableStudy completedNCT03674996
What this trial is testing

Safety and Security Evaluation of Patients Submitted to Minimally Invasive Radical Prostatectomy

Who this might be right for
Prostate Cancer
Barretos Cancer Hospital 72
Testing effectiveness (Phase 2)Study completedNCT00321646
What this trial is testing

Neoadjuvant Bevacizumab Plus Docetaxel in High Risk Patients With Prostate Cancer Undergoing Radical Prostatectomy

Who this might be right for
Prostate CancerAdenocarcinoma of the Prostate
Mary-Ellen Taplin, MD 42
Large-scale testing (Phase 3)Active Not RecruitingNCT00430183
What this trial is testing

Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Alliance for Clinical Trials in Oncology 788
Early research (Phase 1)Study completedNCT00805883
What this trial is testing

MRI Targeted Focal Laser Thermal Therapy of Prostate Cancer Followed by Radical Prostatectomy

Who this might be right for
Prostate Neoplasm
University Health Network, Toronto 10
Not applicableStudy completedNCT04337060
What this trial is testing

Open Radical Prostatectomy and Erector Spinae Plane Block

Who this might be right for
Prostate CancerAnesthesia, LocalPain, Postoperative
BURHAN DOST 52
Testing effectiveness (Phase 2)Study completedNCT04530552
What this trial is testing

Testing the Effects of Low Dose Apalutamide on Prostate-Specific Antigen (PSA) Levels in Men Scheduled for Removal of the Prostate Gland

Who this might be right for
Localized Prostate CarcinomaProstate AdenocarcinomaStage I Prostate Cancer AJCC v8+1 more
National Cancer Institute (NCI) 34
Next Page